Jefferies Financial Group Inc. Pacira Bio Sciences, Inc. Put Options Transaction History

Jefferies Financial Group Inc.

7 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q3 2024 Nov 14, 2024	SELL	$11.7 - $28.46 $890,370 - $2.17 Million	-76,100 Reduced 99.35%	500 $7,000
Q2 2024 Aug 13, 2024	BUY	$25.5 - $31.51 $127,500 - $157,550	5,000 Added 6.98%	76,600 $2.19 Million
Q4 2023 Feb 13, 2024	SELL	$26.32 - $34.31 $73,696 - $96,068	-2,800 Reduced 3.76%	71,600 $2.42 Million
Q3 2023 Nov 14, 2023	BUY	$30.68 - $40.09 $1.61 Million - $2.1 Million	52,400 Added 238.18%	74,400 $2.28 Million
Q2 2023 Aug 14, 2023	SELL	$36.12 - $47.5 $668,220 - $878,750	-18,500 Reduced 45.68%	22,000 $881,000
Q4 2022 Sep 21, 2023	BUY	$38.19 - $57.45 $706,515 - $1.06 Million	18,500 Added 84.09%	40,500 $1.56 Million
Q4 2022 Feb 14, 2023	BUY	$38.19 - $57.45 $1.55 Million - $2.33 Million	40,500 New	40,500 $1.56 Million

263

50.4M

429K

391K

Ticker PCRX
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 45,824,200
Market Cap $892M
Description
Pacira BioSciences, Inc. provides non-opioid pain management and regenerative health solutions for healthcare practitioners and their patients in the United States. The company offers EXPAREL, a bupivacaine liposome injectable suspension; ZILRETTA, a triamcinolone acetonide extended-release injectable suspension; and iovera system, a non-opioid ...

Get notified when there are updates to the investment portfolio of Jefferies Financial Group Inc., based on Form 13F filings with the SEC.

Stay updated on Jefferies Financial Group Inc. with notifications on news.